MiCare Path is expanding across markets in need of musculoskeletal solutions by acquiring SmarTrac, the only “smart” patient compliance sensor on the market today, from OnTracMD.
SmarTrac enables physicians, therapists, nurse case managers and adjustors to monitor critical elements of a home exercise program including compliance, therapy progress and outcome data. SmarTrac is FDA registered.
MiCare Path has developed a reimbursable integrated mobile health platform designed to promote clinical efficiencies for patient experience. The company’s platform builds a connection with patients, guides on wellness, tracks patients’ clinical scores, activity levels and weight by linking it to existing smartphone applications, informing physicians of customer behavior.
MiCare Path will continue to explore and invest in strategic acquisitions that deliver unparalleled value to patients and providers. Financial terms of the deal were not disclosed.
According to data captured in the LevinPro HC database, this acquisition represents the 131st eHealth transaction of 2023, including 10 in the remote patient monitoring specialty.
